BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

A2A Pharmaceuticals

A2A Pharmaceuticals logo

Founded
2016
Patents
2
Publications
1

Technologies

AI Companies (Drug Discovery)

A2A Pharmaceuticals designs computationally optimized small molecule therapeutics for the treatment of cancer and antibiotic resistant bacterial infections. Our two oncology programs are focused on inhibiting essential protein-protein interactions in leukemia and in diverse solid tumors. These interactions are critical for cancer progression, but non-essential in normal cells. The antibiotic programs target biosynthetic enzymes in gram-negative bacteria, in pathways not found in humans. The targets selected have no clinically used therapeutics, minimizing susceptibility to resistance; and unlike the numerous follow-on antibiotics currently in development.

Become a Member to view additional information about this company